CLINICAL ROLE -
Expert continues discussion on important considerations for the optimal use if venetoclax in patients with AML, such as CYP3A4 and p-glycoprotein drug interactions.
FDA Approves Pirtobrutinib For Treatment of Adult Patients With CLL, SLL
Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma
Vaccination Status of Patients with Hematologic Malignancies Not Correlated with Severity of COVID-19 Infection
FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma
Treatment Opportunities Continue to Advance in CLL Management